» Articles » PMID: 16497984

Cerebrovascular Reactivity and Cognitive Decline in Patients with Alzheimer Disease

Overview
Journal Stroke
Date 2006 Feb 25
PMID 16497984
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: The aim of this study was to explore the possible contribution of alterations in cerebral hemodynamics to the evolution of cognitive impairment in patients with Alzheimer disease (AD).

Method: Fifty-three patients with AD were investigated. The evolution of cognitive decline over 12 months was evaluated by means of changes in Mini Mental State Examination (MMSE) and AD Assessment Scale for Cognition (ADAS-Cog) scores. Demographic characteristics, vascular risk profile, pharmacological treatment, and presence of white matter lesions were assessed at entry. Further, a basal evaluation of cerebrovascular reactivity to hypercapnia was measured with transcranial Doppler ultrasonography using the breath-holding index (BHI).

Results: Of all the variables considered, both MMSE and ADAS-Cog changes had the highest correlation with BHI, followed by age and diabetes. After subdividing both cognitive measures reductions into bigger and smaller-than-average decline (2 points for MMSE; 5 points for ADAS-Cog), multiple logistic regression indicated BHI as the sole significant predictor of cognitive decline.

Conclusions: These results show an association between impaired cerebral microvessels functionality and unfavorable evolution of cognitive function in patients with AD. Further research is needed to fully establish whether altered cerebral hemodynamics may be considered an independent factor in sustaining cognitive decline progression or an effect of pathological processes involved in AD.

Citing Articles

Changes in cerebrovascular reactivity as a marker of cognitive impairment risk: a transcranial Doppler study.

Lugnan C, Caruso P, Rossi L, Furlanis G, Naccarato M, Manganotti P J Ultrasound. 2025; .

PMID: 39864049 DOI: 10.1007/s40477-025-00986-0.


The cerebral blood flow response to neuroactivation is reduced in cognitively normal men with β-amyloid accumulation.

Vestergaard M, Bakhtiari A, Osler M, Mortensen E, Lindberg U, Law I Alzheimers Res Ther. 2025; 17(1):4.

PMID: 39754275 PMC: 11699738. DOI: 10.1186/s13195-024-01652-z.


Resting-state functional magnetic resonance imaging study on cerebrovascular reactivity changes in the precuneus of Alzheimer's disease and mild cognitive impairment patients.

Tang X, Wang L, Feng Q, Hu H, Zhu Y, Liao Z Sci Rep. 2025; 15(1):363.

PMID: 39747269 PMC: 11696737. DOI: 10.1038/s41598-024-82769-x.


Editorial: Visualization and assessment of cerebral vasculature, cerebrospinal fluids, and the brain parenchyma in dementia and aging.

Huang J, Zhang Y, Chen L, Jiang D, Lin Z Front Aging Neurosci. 2024; 16:1443028.

PMID: 38957541 PMC: 11217718. DOI: 10.3389/fnagi.2024.1443028.


Cerebrovascular reactivity MRI as a biomarker for cerebral small vessel disease-related cognitive decline: Multi-site validation in the MarkVCID Consortium.

Liu P, Lin Z, Hazel K, Pottanat G, Xu C, Jiang D Alzheimers Dement. 2024; 20(8):5281-5289.

PMID: 38951718 PMC: 11350011. DOI: 10.1002/alz.13888.